Corey Lactone Diol

CAS No. 32233-40-2

Corey Lactone Diol( (-)-Corey lactone diol )

Catalog No. M21346 CAS No. 32233-40-2

Corey Lactone Diol is a pharmaceutical intermediate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG 27 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Corey Lactone Diol
  • Note
    Research use only, not for human use.
  • Brief Description
    Corey Lactone Diol is a pharmaceutical intermediate.
  • Description
    Corey Lactone Diol is a pharmaceutical intermediate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (-)-Corey lactone diol
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    32233-40-2
  • Formula Weight
    172.18
  • Molecular Formula
    C8H12O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:34 mg/mL (197.46 mM)
  • SMILES
    OC[C@H]([C@@H](C1)[C@H](C2)OC1=O)[C@@H]2O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Achmatowicz B Baranowska E Daniewski A R et al. A novel approach to prostaglandins from the corey lactone involving BF3-mediated reactions of a sulphone and aldehydes[J]. Tetrahedron Letters 1985 26(45):5597–5600.
molnova catalog
related products
  • Soyasaponin Bb

    Soyasaponin Bb can suppress Eca-976 cell growth, reverse effects on over expression of c-met, VEGF, and induce cell apoptosis through inhibiting HDAC1-NF-kappaB and activating PETEN and caspase-3 signaling pathways.

  • Bis(2-ethylhexyl)hex...

    Bis(2-ethylhexyl)hexanedioate (NSC 56775) is a diester produced by the formal condensation of the carboxyl group of adipic acid with 2-ethylhexan-1-ol, and is used as a plasticizer in the preparation of various polymers.

  • Allocryptopine

    Allocryptopine has certain effects on anti-injury for hepatocyte, ameliorating liver function, and prohibiting hepatic fibrosis; it increases mRNA levels of cytochromes P450 1A in human hepatocytes and HepG2 cells independently of AhR.